Lindahl legal advisor to Sedana Medical AB (publ) in connection with a change of listing to Nasdaq Stockholm
Lindahl has acted as a legal advisor to Sedana Medical AB (publ) in connection with the company’s change of listing from Nasdaq First North Growth Market to the Nasdaq Stockholm main list.
Trading in the company’s shares commenced on 25 January 2023. The closing price for the company’s share on the first trading day was SEK 27.06 per share, equivalent to a value of approximately SEK 2.7 billion for all shares in Sedana Medical.
Sedana Medical is a medical technology and pharmaceutical company founded in 2004. The company is based in Danderyd, outside Stockholm, and its operations include development, marketing and sale of the medical device Sedaconda ACD and its accessories, as well as the Sedaconda (isoflurane) sedation medication.
Lindahl’s team consisted mainly of Ola Svanberg, Monica Lagercrantz, Mikael Nagy and Ebba Meyer-Lie (capital markets and public M&A), Mårten Lindberg and Asta Schulz (IP/Tech), Matilda Jusslin (employment) and Anna Romell Stenmark (tax).
Do you want to know more? Contact:
Ola Svanberg
Partner | AdvokatMonica Lagercrantz
Partner | AdvokatEbba Meyer-Lie
Senior Associate | AdvokatAnna Romell Stenmark
Partner | AdvokatCarousel items
-
Cases and transactions
7/13/2026
Lindahl Advises Bokusgruppen AB (publ) on the Acquisition of Pen Store Sthlm AB
Lindahl has advised Bokusgruppen on its acquisition of Pen Store, the leading Nordic retailer of pens and artists' materials serving customers across the EU.
-
News articles
7/7/2026
Lindahl included among Sweden's ten most reputable patent firms for the second consecutive year
For the second consecutive year, Lindahl has been named among Sweden's ten most reputable patent law firms by The Patent Lawyer Magazine – a testament to the firm's strong expertise and long-term commitment in intellectual property law.
-
Portraits
7/3/2026
Jesper on business-oriented legal advice in energy: "It is not enough for the advice to be correct"
Lindahl's energy team is recognised in Legal 500 for combining deep regulatory expertise with broad commercial legal experience – find out how they support clients in a rapidly evolving sector.
-
Knowledge
6/29/2026
The scope of the Swedish FDI Act is expanded – is your business affected?
MCF's new regulation (MCFFS 2026:13) expands the scope of the Swedish FDI Act from 15 July 2026. Is your business affected? Read about the key changes.
-
Read more news and insights?
